Business Daily Media

Business Marketing

.

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally

  • Written by ACN Newswire - Press Releases

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally

SHANGHAI, CHINA, Apr 23, 2021 - (ACN Newswire) - Hua Medicine (the "Company", Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the treatment of Type 2 Diabetes (T2D) was accepted by the China National Medical Products Administration (NMPA). Dorzagliatin is the first glucokinase activator (GKA) to

Read more //?#

Popular

Lockdown brings increased digitisation of Australian health and lifestyle habits

nbn Covid-19 Behavioural Change Survey   Lifestyle habits of Australians have undergone a major shift since the COVID-19 pandemic first hit, with record numbers of Australians exploring online substitutes for everything from...

Cost control tips for a small business

Small businesses are forever being squeezed harder due to escalating costs. The insurance premium takes a hike, fuel prices go up, your wholesaler of choice has put up its prices, the list goes on. Given that cash flow is one of...

Linktree Appoints New CPO and Two Technologists

Linktree is a product-led organisation, and has been since day one, focused on growing and innovating our offerings to meet the needs of the over 45M Linkers who rely on Linktree to unify, engage and monetize their online pres...